Pentapharm Revenue and Competitors

Aesch, swi

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pentapharm's estimated annual revenue is currently $19.5M per year.(i)
  • Pentapharm's estimated revenue per employee is $201,000

Employee Data

  • Pentapharm has 97 Employees.(i)
  • Pentapharm grew their employee count by 23% last year.

Pentapharm's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.3M10615%N/AN/A
#2
$98.7M49129%N/AN/A
#3
$130.4M6491%N/AN/A
#4
N/A7878%N/AN/A
#5
$16.3M819%N/AN/A
#6
$39.8M19853%N/AN/A
#7
$20.7M10321%N/AN/A
#8
$15.5M778%N/AN/A
#9
$33.4M1668%N/AN/A
#10
$106.5M5309%N/AN/A
Add Company

What Is Pentapharm?

PENTAPHARM is a company specialized in coagulation diagnostics reagent kits and active pharmaceutical ingredients. We are based in Aesch, northwestern corner of Switzerland. Our roots as researchers, developers and manufacturers of state-of-the-art products reach back to 1948. Founder of the company, Viktor Stürm was inspired by the scientific concept of extraction of natural raw materials derived from plants as well as animal and, translated them into applied science for medical use. This is an important building block for Pentapharm’s long standing tradition.Since its inception in 1948, Pentapharm is a key supplier of the diagnostic industry through its wide range of snake venom enzymes, coagulation factor substrates and inhibitors, and biochemicals that can be combined together for assay development in the field of hemostasis and thrombotic risk assessment.Pentapharm is your partner of choice if you’re looking for active pharmaceutical ingredients, OEM assays or ready-to-use diagnostic kits for laboratory devices or POC applications.Since 2007, Pentapharm is a 100% wholly owned subsidiary of DSM Nutritional Products Ltd.

keywords:N/A

N/A

Total Funding

97

Number of Employees

$19.5M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A18222%N/A